ZyVersa Therapeutics, Inc. — S-1/A Filings
21 S-1/A filings on record
This page lists all S-1/A filings submitted to the SEC by ZyVersa Therapeutics, Inc. (ZVSA), sorted by most recent first. Each row links to the full filing on EdgarLookup. ZyVersa Therapeutics, Inc. has filed 21 S-1/A documents with the SEC since 2021. To view all SEC filings by ZyVersa Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
25-NSE
3
4
424B3
424B4
424B5
425
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
EFFECT
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
S-1
S-1/A
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-1/A | S-1/A | 0001641172-25-021952 | Aug 1, 2025 | — |
| S-1/A | S-1/A | 0001641172-25-020253 | Jul 18, 2025 | — |
| S-1/A | — | 0001493152-23-043877 | Dec 6, 2023 | — |
| S-1/A | — | 0001493152-23-043620 | Dec 5, 2023 | — |
| S-1/A | — | 0001493152-23-042336 | Nov 21, 2023 | — |
| S-1/A | — | 0001493152-23-037493 | Oct 17, 2023 | — |
| S-1/A | — | 0001493152-23-036393 | Oct 5, 2023 | — |
| S-1/A | — | 0001493152-23-023968 | Jul 7, 2023 | — |
| S-1/A | — | 0001493152-23-023162 | Jun 30, 2023 | — |
| S-1/A | — | 0001493152-23-013293 | Apr 24, 2023 | — |
| S-1/A | — | 0001493152-23-012648 | Apr 18, 2023 | — |
| S-1/A | — | 0001493152-23-011896 | Apr 12, 2023 | — |
| S-1/A | — | 0001493152-23-010889 | Apr 5, 2023 | — |
| S-1/A | — | 0001493152-23-004396 | Feb 13, 2023 | — |
| S-1/A | — | 0001493152-23-003308 | Feb 1, 2023 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-21-063736 | Dec 7, 2021 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-21-057114 | Nov 8, 2021 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-21-048448 | Sep 17, 2021 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-21-038935 | Jul 27, 2021 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-21-035978 | Jul 7, 2021 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-21-033318 | Jun 21, 2021 | — |